CLINICAL COURSE AND THERAPEUTIC STRATEGIES OF CHRONIC GASTRITIS
Article Sidebar
Main Article Content
Abstract
Chronic gastritis is a persistent inflammatory disease of the gastric mucosa that develops gradually and can progress silently over time. Its clinical course is often nonspecific, marked by symptoms such as epigastric discomfort, early satiety, nausea, and bloating, which are frequently overlooked. The condition is most commonly associated with Helicobacter pylori infection, autoimmune reactions, or prolonged NSAID use. If left untreated, chronic gastritis can lead to atrophic changes, anemia, and even gastric carcinoma. Accurate diagnosis through endoscopy and histology, along with etiologically guided therapy, is essential for effective management. Treatment typically includes eradication of H. pylori, acid suppression, nutritional support, and lifestyle modification. This article highlights the importance of early recognition, individualized treatment strategies, and long-term surveillance in preventing complications and improving patient outcomes.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
How to Cite
References
Dinis-Ribeiro, M., Areia, M., de Vries, A. C., et al. (2012).
Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the ESGE, EHSG, ESP, and SPED.
Endoscopy, 44(1), 74–94.
DOI: 10.1055/s-0031-1291491
2.Sugano, K., Tack, J., Kuipers, E. J., et al. (2015).
Guidelines for the management of Helicobacter pylori infection.
Journal of Gastroenterology, 50(6), 585–600.
DOI: 10.1007/s00535-015-1073-5
3.El-Serag, H. B., Graham, D. Y. (2017).
Epidemiology of Helicobacter pylori infection and public health implications.
Helicobacter, 22(Suppl 1), e12340.
DOI: 10.1111/hel.12340
4.Lahner, E., Zagari, R. M., Zullo, A., et al. (2019).
Chronic atrophic gastritis: natural history, diagnosis, and therapeutic management.
World Journal of Gastroenterology, 25(29), 3540–3551.
DOI: 10.3748/wjg.v25.i29.3540
5.Kusters, J. G., van Vliet, A. H. M., Kuipers, E. J. (2006).
Pathogenesis of Helicobacter pylori infection.
Clinical Microbiology Reviews, 19(3), 449–490.
DOI: 10.1128/CMR.00054-05